The BRICS TimesRussian scientists have launched clinical trials for a high-tech vaccine designed to fight the spread of Dengue fever globally.
The Federal Medical-Biological Agency (FMBA) of Russia has successfully created a genetically engineered vaccine to combat Dengue fever. Veronika Skvortsova, the head of the FMBA, confirmed that clinical trials are officially moving forward.
“A recombinant genetically engineered vaccine against dengue fever has been developed, and its clinical trials are beginning,” she stated during an FMBA meeting.
The agency head noted that the project began after a direct request from Daniel Ortega, the President of Nicaragua.
Understanding Dengue Fever and Its Origins
Dengue is a viral illness that spreads through bites from infected Aedes mosquitoes. It is mostly found in tropical areas like Southeast Asia, Latin America, and Africa. However, the virus is now reaching new regions due to global warming and more international travel.
The virus has four different types. If you catch one, you stay immune to it for life. However, catching a different type later can actually make the illness much more dangerous.
How the Virus Spreads
You cannot catch Dengue directly from another person. Instead, mosquitoes act as the middleman. A mosquito bites an infected person, carries the virus, and then passes it to the next person it bites.
Cities are high-risk zones for these mosquitoes. Stagnant water in old tires or open containers provides the perfect place for them to breed. This makes crowded urban areas very likely to see sudden outbreaks.
Recognizing Symptoms and Health Risks
Dengue often feels like an extremely bad case of the flu. Patients usually experience very high fevers and intense muscle pain. This pain is so sharp it is often called “breakbone fever.”
Other signs include severe headaches, pain behind the eyes, rashes, and vomiting. Most people recover in two weeks. Yet, some develop “severe dengue,” which leads to internal bleeding. Quick medical care is vital to prevent organ damage or death.
The Importance of a New Vaccine
There is currently no specific medicine to cure Dengue. Doctors usually focus on managing the symptoms. Creating a vaccine is hard because it must protect against all four types of the virus at once.
This new Russian vaccine uses recombinant technology. This approach aims to create a strong immune response. It is designed to be safer and more effective than older vaccine methods.
Global Impact of the Disease
Dengue fever is a massive health crisis affecting millions of people every year. The World Health Organization ranks it as a top global threat. It hits hardest in places where hospitals are already under pressure.
Nicaragua’s role in this project shows how desperate many countries are for a solution. If this vaccine works, it could be a major win for global health and disease control.
The Road Ahead for the Vaccine
The next step is the clinical trial phase. Scientists will test the vaccine on human volunteers to ensure it is safe. These tests start with small groups before expanding to thousands of people.
If the results are positive, this vaccine could become a primary tool. It would help reduce the massive number of Dengue cases reported across the world each year.
